RGNT
HEALTHCARERegentis Biomaterials Ltd.
What's Moving RGNT Today?
No stock-specific AI insight has been generated for RGNT yet. Check back soon — insights are generated from recent news analysis.
Market Briefings featuring RGNT
52-Week Range
$1.74
Fundamentals
Trading
RGNT News
23 articles- Regentis Biomaterials (RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin CYahoo Finance·Jul 30, 2026
- Regentis Biomaterials (RGNT) Positioned to Benefit as Regenerative Medicine Reshapes the Growing $3B Cartilage Repair MarketYahoo Finance·Jul 27, 2026
- Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing TechnologyYahoo Finance·Jul 20, 2026
- Regentis Biomaterials (RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing ProcessYahoo Finance·Jul 16, 2026
- Regentis Receives European Regulatory Approval for New GelrinC Manufacturing Process, Increasing Production Yield by 400% Ahead of European Commercial LaunchYahoo Finance·Jul 15, 2026
- Regentis Biomaterials Ltd Actuals & Estimates (AMEX:RGNT)TradingView·Jun 26, 2026
- Regentis Biomaterials Announces Pricing of a $6.5 Million Private PlacementYahoo Finance·Jun 18, 2026
- This Monthly Dividend Powerhouse Is Trading at a Bargain-Bin ValuationBarchart·Jun 16, 2026
- Regentis Biomaterials Stock Falls Premarket After 506% Surge on Scrapped Share OfferingTechStock²·Jun 16, 2026
- Regentis Biomaterials Slips 9% After Soaring 506% On Monday — Here's Why RGNT Stock Is TrendingBenzinga·Jun 16, 2026
- Why Did RGNT Stock Surge More Than 850% Today?Stocktwits·Jun 15, 2026
- Regentis Biomaterials (RGNT) Advances European Commercial Launch Plans for GelrinCNewMediaWire·Jun 8, 2026
- Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations AccelerateYahoo Finance·Jun 8, 2026
- Regentis Biomaterials (RGNT) Advances Simplified Cartilage Repair Platform Toward Key Commercial MilestonesYahoo Finance·Jun 1, 2026
- Regentis Biomaterials (RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative ImplantYahoo Finance·May 29, 2026
- Regentis Biomaterials (RGNT) Is 'One to Watch'Yahoo Finance·May 28, 2026
- Regentis Biomaterials (RGNT) and the Off-the-Shelf Opportunity in Knee Cartilage RepairYahoo Finance·May 26, 2026
- Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta KonYahoo Finance·Apr 16, 2026
- Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%Yahoo Finance·Mar 17, 2026
- Regentis Biomaterials Reports 2025 Financial Results and Provides Business UpdateYahoo Finance·Feb 24, 2026
- Regentis Biomaterials (RGNT) Appoints New CFO/CBO as GelrinC Nears Commercial LaunchYahoo Finance·Feb 24, 2026
- Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage RepairYahoo Finance·Feb 19, 2026
- Regentis Expands its European Clinical Site Network to Support its Commercial and Clinical ProgramsYahoo Finance·Feb 17, 2026
All 23 articles loaded
Price Data
52-Week Range
$1.74
Fundamentals
Trading
About Regentis Biomaterials Ltd.
Regent Assisted Living Inc. is a leading provider of premium assisted living and memory care services, committed to enhancing the quality of life for seniors through customized care and supportive living environments. With a nationwide network of facilities, Regent distinguishes itself through modern amenities and a compassionate, professional staff dedicated to resident well-being. By employing innovative care models and fostering strong community ties, the company consistently elevates its service offerings in a burgeoning senior living market. As the demand for senior care solutions continues to rise, Regent's strategic growth initiatives present a compelling investment opportunity for institutional investors seeking to capitalize on trends within the expanding healthcare sector.